Review of the AMADEO study: reducing proteinuria in patients with diabetic nephropathy with telmisartan versus losartan. Commentary
- PMID: 20203469
- DOI: 10.3810/pgm.2010.03.2135
Review of the AMADEO study: reducing proteinuria in patients with diabetic nephropathy with telmisartan versus losartan. Commentary
Comment on
-
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.Kidney Int. 2008 Aug;74(3):364-9. doi: 10.1038/ki.2008.204. Epub 2008 May 21. Kidney Int. 2008. PMID: 18496508 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources